Effect of angiotensin II type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients

Documenti analoghi

• Determination of the clinical relevance of donor epitope‐specific HLA‐antibodies in kidney transplantation
  di: Tineke Kardol‐Hoefnagel, et al.
  Pubblicazione: (2024)
• A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor‐specific anti HLA antibodies
  di: Sandra García‐Jiménez, et al.
  Pubblicazione: (2024)
• Evaluation of rapid optimized flow cytometry crossmatch (Halifaster) in living donor kidney transplantation
  di: Luis Ramalhete, et al.
  Pubblicazione: (2024)
• Multi‐centre analytical performance verification of an IVD assay to quantify donor‐derived cell‐free DNA in solid organ transplant recipients
  di: Sílvia Casas, et al.
  Pubblicazione: (2024)
• A simple predictor for donor‐specific anti‐HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation
  di: Jia‐Ming Li, et al.
  Pubblicazione: (2024)